Cancer Research Folkman
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, S.-L.
Right arrow Articles by Wang, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, S.-L.
Right arrow Articles by Wang, X.-J.
[Cancer Research 64, 4405-4410, July 1, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Overexpression of Transforming Growth Factor ß1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation

Shi-Long Lu1, Douglas Reh1, Allen G. Li1, Jennifer Woods1, Christopher L. Corless2, Molly Kulesz-Martin3,4 and Xiao-Jing Wang1,3,4

Departments of 1 Otolaryngology, 2 Pathology, 3 Dermatology, and 4 Cell and Developmental Biology, Oregon Health & Science University, Portland, Oregon

In the present study, we show that transforming growth factor ß1 (TGF-ß1) was frequently overexpressed in human head and neck squamous cell carcinomas (HNSCCs) and adjacent tissues in comparison with normal head and neck tissues. To determine the role of TGF-ß1 overexpression in HNSCC carcinogenesis, we generated transgenic mice in which TGF-ß1 transgene expression can be induced in head and neck epithelia. TGF-ß1 transgene induction in head and neck epithelia, at levels similar to those in human HNSCCs, caused severe inflammation and angiogenesis. Consequently, TGF-ß1-transgenic epithelia exhibited hyperproliferation. These phenotypes correlated with enhanced Smad signaling in transgenic epithelia and stroma. Our study suggests that TGF-ß1 overexpression at early stages of HNSCC formation provides a tumor promoting microenvironment.




This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Yang and H. L. Moses
Transforming Growth Factor {beta}: Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?
Cancer Res., November 15, 2008; 68(22): 9107 - 9111.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yu, G. C. Sharp, and H. Braley-Mullen
TGF-{beta} Promotes Thyroid Epithelial Cell Hyperplasia and Fibrosis in IFN-{gamma}-Deficient NOD.H-2h4 Mice
J. Immunol., August 1, 2008; 181(3): 2238 - 2245.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. E. Diamond, L. Sun, A. J. Ottaviano, M. J. Joseph, and H. G. Munshi
Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium
J. Cell Sci., July 1, 2008; 121(13): 2197 - 2207.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
L. Sun, M. E. Diamond, A. J. Ottaviano, M. J. Joseph, V. Ananthanarayan, and H. G. Munshi
Transforming Growth Factor-{beta}1 Promotes Matrix Metalloproteinase-9-Mediated Oral Cancer Invasion through Snail Expression
Mol. Cancer Res., January 1, 2008; 6(1): 10 - 20.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. B. Glick, R. Perez-Lorenzo, and J. Mohammed
Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis
Carcinogenesis, January 1, 2008; 29(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Dennler, J. Andre, I. Alexaki, A. Li, T. Magnaldo, P. ten Dijke, X.-J. Wang, F. Verrecchia, and A. Mauviel
Induction of Sonic Hedgehog Mediators by Transforming Growth Factor-{beta}: Smad3-Dependent Activation of Gli2 and Gli1 Expression In vitro and In vivo
Cancer Res., July 15, 2007; 67(14): 6981 - 6986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. McMahon, M. Charbonneau, S. Grandmont, D. E. Richard, and C. M. Dubois
Transforming Growth Factor beta1 Induces Hypoxia-inducible Factor-1 Stabilization through Selective Inhibition of PHD2 Expression
J. Biol. Chem., August 25, 2006; 281(34): 24171 - 24181.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S.-L. Lu, H. Herrington, D. Reh, S. Weber, S. Bornstein, D. Wang, A. G. Li, C.-F. Tang, Y. Siddiqui, J. Nord, et al.
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.
Genes & Dev., May 15, 2006; 20(10): 1331 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. I. Koster, S.-L. Lu, L. D. White, X.-J. Wang, and D. R. Roop
Reactivation of Developmentally Expressed p63 Isoforms Predisposes to Tumor Development and Progression.
Cancer Res., April 15, 2006; 66(8): 3981 - 3986.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. G. Li, S.-L. Lu, M.-X. Zhang, C. Deng, and X.-J. Wang
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Cancer Res., November 1, 2004; 64(21): 7836 - 7845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.